Dermata Therapeutics Inc. (DRMA)
NASDAQ: DRMA
· Real-Time Price · USD
5.90
0.09 (1.55%)
At close: Aug 15, 2025, 3:59 PM
5.98
1.36%
After-hours: Aug 15, 2025, 04:00 PM EDT
Dermata Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -10.33M | -11.46M | -12.29M | -11.27M | -9.82M | -8.69M | -7.79M | -7.33M | -8.04M | -9.06M | -9.61M | -10.49M | -9.78M | -8.38M | -7.9M | -5.75M | -4.63M | -4.12M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 127.23K | 107.6K | 657.65K | 756.3K | 866.49K | 978.06K | 522.08K | 614.5K | 718.31K | 848.71K | 930.33K | 1.2M | 1.11M | 958.24K | 1.91M | 1.42M | 1.27M | 1.16M |
Other Working Capital | 639.78K | 919.59K | 575.38K | 736.31K | 412.22K | -82.67K | 494.35K | -362.06K | -388.38K | 509.61K | -135.03K | 769.59K | 487.69K | -273.91K | -121.42K | -674.84K | -688.41K | -570.72K |
Other Non-Cash Items | -769.27K | 259.36K | 259.36K | 259.36K | n/a | 131.18K | 131.18K | 352.07K | 587.05K | 402.45K | 615.33K | 883.16K | 648.33K | 701.83K | 502.84K | -110.66K | -94.68K | -79.58K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 13.72K | 697.27K | 207.51K | 858.2K | 1.2M | 247K | 863.68K | -371.34K | -559.41K | 340.25K | -153.58K | 483.47K | 215.2K | -99.77K | 289.55K | 14.44K | -133.97K | -385.9K |
Operating Cash Flow | -10.96M | -10.39M | -11.16M | -9.4M | -7.75M | -7.46M | -6.41M | -7.09M | -7.88M | -7.88M | -8.83M | -8.81M | -8.46M | -7.53M | -5.69M | -4.43M | -3.59M | -3.43M |
Capital Expenditures | -3 | n/a | 4.00 | 5.00 | 8.00 | 5.00 | 5.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.01M | 1.32M | 2.69M | 2.69M |
Common Stock Repurchased | 828.00 | n/a | n/a | n/a | -863.42 | -35.42 | -75.42 | -75.42 | -40 | -40 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -476.75K | 1.11K | 1.11K | 168.00 | -70K | 34.00 | 227.00 | 4.27B | 4.27B | 4.27B | 4.27B | 287.00 | 87.00 | n/a | 570K | 570K | 588.75K | 1.21M |
Financial Cash Flow | 12.49M | 15.38M | 6.89M | 8.91M | 4.26M | 3.43M | 7.61M | 4.27B | 4.27B | 4.28B | 4.27B | 4.28M | 18.66M | 14.39M | 15.96M | 16.28M | 3.28M | 4.14M |
Net Cash Flow | 1.53M | 4.99M | -4.28M | -487.73K | -3.49M | -4.03M | 1.2M | -1.44M | -2.19M | 575.8K | -4.56M | -4.54M | 10.2M | 6.86M | 10.27M | 11.85M | -309.5K | 717.68K |
Free Cash Flow | -10.96M | -10.39M | -11.16M | -9.4M | -7.75M | -7.46M | -6.41M | -7.09M | -7.88M | -7.88M | -8.83M | -8.81M | -8.46M | -7.53M | -5.69M | -4.43M | -3.59M | -3.43M |